MedPath

Prognostic study of ischemic heart diseases in Hokuriku district: prospective investigation for predicting adverse cardiac event rates

Not Applicable
Conditions
ischemic heart disease
Registration Number
JPRN-UMIN000001823
Lead Sponsor
Kanazawa University
Brief Summary

Validity of J-ACCESS risk model was confirmed in patients with coronary artery disease (n=283). J Cardiol. 2018 Jul;72(1):81-86. doi: 10.1016/j.jjcc.2017.12.006. Epub 2018 Jan 6.

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete: follow-up complete
Sex
All
Target Recruitment
300
Inclusion Criteria

Not provided

Exclusion Criteria

Cardiomyopathy Valvular heart disease Severe liver dysfunction Renal dysfunction requiring hemodialysis Acute coronary syndrome within the onset of 3 months Severe arrhythmia Severe heart failure of NYHA III or IV

Study & Design

Study Type
Observational
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Adverse cardiac events: cardiac death, non-fatal myocardial infarction
Secondary Outcome Measures
NameTimeMethod
Other cardiovascular events
© Copyright 2025. All Rights Reserved by MedPath